CGRP Monoclonal Antibodies for Migraine: Rationale and Progress

Overview of attention for article published in BioDrugs, November 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#46 of 747)
High Attention Score compared to outputs of the same age (88th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

news: 1 news outlet
twitter: 13 X users

facebook: 1 Facebook page
googleplus: 1 Google+ user

Citations

dimensions_citation: 49 Dimensions

Readers on

mendeley: 121 Mendeley

Summary News X Facebook Google+ Dimensions citations

So far, Altmetric has seen 1 Google+ post.

07 Nov 2017

CGRP Monoclonal Antibodies for Migraine: Rationale and Progress CGRP Monoclonal Antibodies for Migraine: Rationale and Progress…

This page shows the most recent Google+ posts that mention this research output.

Click here to find out how to access more activity.